Synaptobrevin2/VAMP2 (syb2) is a synaptic vesicle associated protein critical for normal synaptic transmission in central synapses. Its interaction with plasma membrane associated proteins syntaxin1 and SNAP-25 is thought to be an important step in synaptic vesicle fusion. These proteins are called SNAREs (acronym for soluble NSF attachment protein receptors). Despite extensive progress on characterization of molecular interactions between SNAREs, their precise role in synaptic transmission remains elusive. Knockout mice lacking syb2 exhibit a lethal phenotype and die at birth. In preliminary experiments, analysis of hippocampal cultures extracted from these mice revealed a persistent form of regulated exocytosis and synaptic vesicle recycling. This result supports a role for SNAREs in regulating the rate and Ca2+-dependence of neurotransmission rather than an executive function in driving fusion. The main objective of this project is to test the hypotheses that emerge from this initial analysis of syb2 deficient mice and elucidate the role of syb2 and its interactions with other SNAREs in synaptic vesicle exocytosis and recycling in mammalian central synapses. 1. To determine the molecular basis for synaptic vesicle fusion and recycling observed in syb2 deficient synapses, the involvement of other SNAREs or vesicle membrane associated proteins in the remaining neurotransmission will be tested. 2. The role of SNARE interactions in vesicle retrieval and recycling will be investigated using styryl dye imaging. 3. To define structural requirements for syb2 function, wild type and mutant syb2 constructs will be introduced to hippocampal cultures obtained from knockout mice to study in vitro rescue. Information attained from this study will also provide new insight to the disease process in psychiatric and neurological disorder such as mental retardation, schizophrenia and epilepsy leading to design of new therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH066198-01A2
Application #
6724659
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Asanuma, Chiiko
Project Start
2003-12-01
Project End
2008-11-30
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
1
Fiscal Year
2004
Total Cost
$280,800
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Physiology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Chanaday, Natali L; Kavalali, Ege T (2018) Presynaptic origins of distinct modes of neurotransmitter release. Curr Opin Neurobiol 51:119-126
Kavalali, Ege T (2018) Spontaneous neurotransmission: A form of neural communication comes of age. J Neurosci Res 96:331-334
Liu, Pei; Khvotchev, Mikhail; Li, Ying C et al. (2018) Copine-6 Binds to SNAREs and Selectively Suppresses Spontaneous Neurotransmission. J Neurosci 38:5888-5899
Chanaday, Natali L; Kavalali, Ege T (2018) Optical detection of three modes of endocytosis at hippocampal synapses. Elife 7:
Schaukowitch, Katie; Reese, Austin L; Kim, Seung-Kyoon et al. (2017) An Intrinsic Transcriptional Program Underlying Synaptic Scaling during Activity Suppression. Cell Rep 18:1512-1526
Li, Ying C; Kavalali, Ege T (2017) Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets. Pharmacol Rev 69:141-160
Crawford, Devon C; Ramirez, Denise M O; Trauterman, Brent et al. (2017) Selective molecular impairment of spontaneous neurotransmission modulates synaptic efficacy. Nat Commun 8:14436
Afuwape, Olusoji A T; Wasser, Catherine R; Schikorski, Thomas et al. (2017) Synaptic vesicle pool-specific modification of neurotransmitter release by intravesicular free radical generation. J Physiol 595:1223-1238
Darios, Frederic D; Jorgacevski, Jernej; Flašker, Ajda et al. (2017) Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion. Sci Rep 7:5958
Horvath, Patricia M; Kavalali, Ege T; Monteggia, Lisa M (2017) CRISPR/Cas9 system-mediated impairment of synaptobrevin/VAMP function in postmitotic hippocampal neurons. J Neurosci Methods 278:57-64

Showing the most recent 10 out of 53 publications